HLB Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	696,200	934,494	331,363	365,136	378,914	776,712	Upgrade
Market Cap Growth	182.02%	182.02%	-9.25%	-3.64%	-51.22%	0.46%	Upgrade
Enterprise Value	706,183	946,064	315,400	359,859	380,861	785,427	Upgrade
Last Close Price	8310.00	11152.38	4176.19	5152.98	6290.08	12980.24	Upgrade
PS Ratio	12.53	17.01	6.30	8.61	8.69	18.09	Upgrade
PB Ratio	4.42	5.14	1.93	2.85	2.91	7.74	Upgrade
P/TBV Ratio	6.37	6.37	2.21	3.28	3.31	9.64	Upgrade
P/FCF Ratio	1069.78	1435.95	109.54	-	-	-	Upgrade
P/OCF Ratio	725.68	725.68	99.60	-	-	-	Upgrade
EV/Sales Ratio	12.86	17.22	6.00	8.49	8.74	18.30	Upgrade
EV/EBITDA Ratio	2022.13	2022.13	-	-	-	-	Upgrade
EV/FCF Ratio	1085.12	1453.73	104.26	-	-	-	Upgrade
Debt / Equity Ratio	0.13	0.13	0.06	0.41	0.39	0.13	Upgrade
Debt / EBITDA Ratio	49.91	49.91	-	-	-	-	Upgrade
Debt / FCF Ratio	35.88	35.88	3.31	-	-	-	Upgrade
Asset Turnover	0.26	0.26	0.27	0.23	0.28	0.33	Upgrade
Inventory Turnover	8.40	8.40	7.70	7.66	13.82	11.14	Upgrade
Quick Ratio	1.46	1.46	1.58	1.24	1.91	1.82	Upgrade
Current Ratio	1.70	1.70	1.86	1.37	2.00	2.07	Upgrade
Return on Equity (ROE)	-12.97%	-12.97%	-1.98%	-8.97%	-15.42%	-19.73%	Upgrade
Return on Assets (ROA)	-2.27%	-2.27%	-2.85%	-2.49%	-4.45%	-5.39%	Upgrade
Return on Capital (ROIC)	-2.46%	-2.46%	-3.06%	-2.60%	-4.70%	-5.91%	Upgrade
Earnings Yield	-3.27%	-2.44%	-0.69%	-3.11%	-4.54%	-2.18%	Upgrade
FCF Yield	0.09%	0.07%	0.91%	-3.34%	-3.19%	-1.51%	Upgrade
Buyback Yield / Dilution	-6.36%	-6.36%	-14.46%	-10.86%	-7.26%	-4.63%	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.